|
Index of reports
> Cases resulting in disability (23)
> Cases with Hyperlactacidaemia (3)
Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in disability where reactions include hyperlactacidaemia.
Adverse event in 23 year old male receiving Zerit (Stavudine)
Reported by a physician from Japan on 2007-06-05
Patient: 23 year old male
Adverse reactions / side effects: Hyperlactacidaemia, Osteonecrosis, Arthralgia, Joint Dislocation, Gait Disturbance
Adverse event resulted in: disablity
Suspect drug(s):
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-03-29
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 1995-10-30
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-01-14
Stocrin
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 1999-03-29
End date: 2002-03-03
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-04
End date: 2002-03-03
Norvir
Dosage: 400mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 1997-11-11
End date: 1998-03-11
Kaletra
Dosage: 6cap per day
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-04
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1997-02-11
End date: 1998-03-11
Serostim
Indication: Weight Decreased
Start date: 2001-04-23
End date: 2005-06-23
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 1993-05-15
End date: 1997-11-11
Other drugs received by patient: Loperamide Hydrochloride; Epivir; Hivid; Prozei; Recombinate; Pegasys; Rebetol
Adverse event in 23 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-20
Patient: 23 year old male, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: Cachexia, Hyperlactacidaemia, Osteonecrosis, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Zerit
Dosage: 22-oct-2002 decreased to 60 mg daily from 80 mg daily.
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1998-01-14
End date: 2004-05-27
Videx
Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1995-10-30
Videx
Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
Administration route: Oral
Indication: HIV Infection
Start date: 1995-10-30
Videx EC
Start date: 2001-04-21
Stocrin Caps
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-03-29
End date: 2002-03-03
Reyataz
Administration route: Oral
Start date: 2004-10-08
Viracept
Dosage: initiated at 500 mg three times daily to 11-nov-1997, restarted 17-aug-1999
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1997-08-04
End date: 2002-03-03
Ziagen
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-03-29
Kaletra
Dosage: dosage form=dose
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2002-03-04
Somatropin
Indication: Weight Decreased
Start date: 2001-04-23
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-04
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1997-11-11
End date: 1998-03-11
Other drugs received by patient: Lopemin; Recombinate; Amprenavir; Retrovir; Epivir; Hivid; Prozei; Loxonin; Celestone
Adverse event in 23 year old male receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-16
Patient: 23 year old male, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: Cachexia, Hyperlactacidaemia, Osteonecrosis, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Zerit
Dosage: 22-oct-2002 decreased to 60 mg daily from 80 mg daily.
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1998-01-14
End date: 2004-05-27
Videx
Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1995-10-30
Videx
Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
Administration route: Oral
Indication: HIV Infection
Start date: 1995-10-30
Videx EC
Start date: 2001-04-21
Stocrin Caps
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-03-29
End date: 2002-03-03
Reyataz
Administration route: Oral
Start date: 2004-10-08
Viracept
Dosage: initiated at 500 mg three times daily to 11-nov-1997, restarted 17-aug-1999
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1997-08-04
End date: 2002-03-03
Ziagen
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-03-29
Kaletra
Dosage: dosage form=dose
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2002-03-04
Somatropin
Indication: Weight Decreased
Start date: 2001-04-23
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-04
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1997-11-11
End date: 1998-03-11
Other drugs received by patient: Lopemin; Recombinate; Amprenavir; Retrovir; Epivir; Hivid; Prozei; Loxonin; Celestone
|
